Lixtes LB-100 A New Dawn in Cancer Therapy with Oncogenic Signaling Innovations,
LIXTE Unveils Groundbreaking Data on LB-100 at Global Oncology Conference In a recent stride towards innovative cancer therapy, Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) made significant waves at the inaugural Gl...
Aug 30, 2025
• Major Pharmaceutical Preparations Industry
Product Service News
$LIXT